Back to Agenda
The ChatBot Will See You Now: Ethical Considerations in Incorporating AI into Informed Consent
Session Chair(s)
Lindsay McNair, MD, MPH, MS
Principal Consultant
Equipoise Consulting, United States
Generative AI is gaining traction in trial communications, with goals of expediency and efficiency. New technologies should incorporate patient views and ethical frameworks to keep human interactions that are desirable, necessary, and useful.
Learning Objective : Describe the ethical framework that encompasses informed consent for clinical research; Evaluate goals for the use of artificial intelligence (AI) in clinical trials and how these goals interact with ethical goals for consent; Discuss how to incorporate patient and participant needs and perspective into AI-assisted clinical trial information and communication.
Speaker(s)
Patient Perspective Update
Deborah Collyar
Patient Advocates In Research (PAIR), United States
President
Industry Update
Karla Childers, MS
Johnson & Johnson, United States
Head, Bioethics-Based Science and Technology Policy
Industry Update
Catina O'Leary, PhD
Health Literacy Media, United States
President and Chief Executive Officer
Have an account?